Longterm effects of hormone replacement therapy on symptoms of angina pectoris, quality of life and compliance in women with coronary artery disease

Maturitas

Volumn 28, Issue 3, 1998, Pages 235-242

  Hall, Gerd ^a   Pripp, Ulla ^a   Schenck Gustafsson, Karin ^a   Landgren, Britt Marie ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Compliance; Coronary artery disease; Hormone replacement therapy; Quality of life; Symptoms of angina pectotis

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTRONE; ESTRONE SULFATE; FOLLITROPIN; MEDROXYPROGESTERONE ACETATE; PLACEBO; PREMARINA; UNCLASSIFIED DRUG; DRUG DERIVATIVE; PROGESTERONE DERIVATIVE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BALLOON DILATATION; CLIMACTERIUM; CLINICAL TRIAL; COGNITION; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; HEART INFARCTION; HEART PALPITATION; HORMONE SUBSTITUTION; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MOOD; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TRANSDERMAL DRUG ADMINISTRATION; TRANSIENT ISCHEMIC ATTACK; BLOOD; COHORT ANALYSIS; COMPARATIVE STUDY; DRUG EFFECT; ESTROGEN THERAPY; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; POSTMENOPAUSE; PSYCHOLOGICAL ASPECT; SAFETY; STANDARD; TIME;

AGED; ANGINA PECTORIS; COHORT STUDIES; CORONARY DISEASE; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); ESTRONE; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; PATIENT COMPLIANCE; POSTMENOPAUSE; PROGESTERONE CONGENERS; QUALITY OF LIFE; SAFETY; TIME FACTORS;

EID: 0032509605     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(97)00080-7     Document Type: Article

References (18)

1. Williams KJ, Adams MR, Klopfenstein HS Estrogen modulates response of atherosclerotic coronary arteries. Circulation. 81:1990;1683-1687.
2. Barret-Connor E, Bush TL Estrogen and coronary heart disease in women. J Am Med Assoc. 265:1991;1861-1867.
3. Stamfer MJ, Colditz GA, Willett WC et al. Postmenopausal estrogen therapy and cardiovascular disease. New Engl J Med. 325:1991;756-762.
4. Daly E, Vessey MP, Hawkins MM, Carson JC, Grough P, March S Risk of venous thromboembolism in users of hormone replacement therapy. Lancet. 348:1996;977-998.
5. Jick LH, Derby LE, Wald Myers M, Vasilakis C, Newton KM Risk of hospital admission for idiopatic venous thromboembolism among users of postmenopausal estrogens. Lancet. 348:1996;981-983.
6. Grodstein F, Stampfer MJ, Goldhaber SZ et al. Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet. 348:1996;983-986.
7. Limouzin-Lamothe M-A, Mairon N, Joyce LRB, Le Gal M Quality of life after menopause: Influence of hormonal replacement therapy. Am J Obstet Gynecol. 170:1994;618-624.
8. Wiklund J, Berg G, Hammar M, Karlberg J, Lindgren R, Sandin K Long-term effect of transdermal hormonal therapy on aspects of quality of life in postmenopausal women. Maturitas. 3:1992;225-236.
9. Campeau L. Grading of angina pectoris. Circulation. 43:1976;522.
10. Wiklund I, Holst J, Karlberg J et al. A new methodological approach for evaluation of quality of life in postmenopausal women. Maturitas. 14:1992;211-224.
11. Aedo A-R, Sundén M, Landgren B-M, Diczfalusy E Effect of orally administered estrogens on circulating estrogen profiles in post-menopausal women. Maturitas. 11:1989;159-168.
12. Sarrel PM Ovarian hormones and the circulation. Maturitas. 12:1990;287-298.
13. Albertsson P, Emanuelsson H, Milsom I Beneficial effect of treatment with transdermal estradiol-17β on exercise-induced angina and ST-segment depression in syndrome X. Int J Cardiol. 54:1997;13-20.
14. Rosano GM, Peters NS, Lefroy D, Lindsey DC, Sarrel PM, Collins P 17β-Estradiol therapy lessens angina in postmenopausal women with syndrome X. JACC. 28(6):1996;1500-1505.
15. Rosano GM, Sarrel P, Posle-Wilson P, Collins P Beneficial effects of estrogen on exercise induced myocardial ischemia in women with coronary artery disease. Lancet. 342:1993;133-136.
16. Hammond CB Women's concerns with hormonal replacement therapy-compliance issues. Fertil Steril. 62(suppl 2):1994;1575-1605.
17. Eiken P, Kolthoff N Compliance with long-term oral hormonal replacement therapy. Maturitas. 22:1995;97-103.
18. Ession DR, Kelly A-C, Jewelewicz R Current concepts in estrogen replacement therapy in the menopause. Fertil Steril. 59:1993;277-284.